- Home
- RCKT vs PRG Comparison
RCKT vs PRG Comparison
Compare RCKT & PRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RCKT | PRG |
|---|---|---|
| Founded | 1999 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Diversified Commercial Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 340.9M | 1.4B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | RCKT | PRG |
|---|---|---|
| Price | $3.24 | $30.08 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 7 |
| Target Price | $29.12 | ★ $37.50 |
| AVG Volume (30 Days) | ★ 2.0M | 573.0K |
| Earning Date | 11-06-2025 | 10-22-2025 |
| Dividend Yield | N/A | ★ 1.70% |
| EPS Growth | N/A | ★ 10.59 |
| EPS | N/A | ★ 3.96 |
| Revenue | N/A | ★ $2,507,179,000.00 |
| Revenue This Year | N/A | $1.32 |
| Revenue Next Year | N/A | $0.64 |
| P/E Ratio | ★ N/A | $7.74 |
| Revenue Growth | N/A | ★ 3.71 |
| 52 Week Low | $2.19 | $23.50 |
| 52 Week High | $13.35 | $44.86 |
Technical Indicators
Market Signals| Indicator | RCKT | PRG |
|---|---|---|
| Relative Strength Index (RSI) | 46.75 | 52.50 |
| Support Level | $3.30 | $29.38 |
| Resistance Level | $3.57 | $31.26 |
| Average True Range (ATR) | 0.18 | 0.99 |
| MACD | -0.01 | 0.11 |
| Stochastic Oscillator | 26.32 | 63.64 |
Price Performance
Historical ComparisonAbout RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.
About PRG PROG Holdings Inc.
PROG Holdings Inc is a financial technology holding company that provides transparent and competitive payment options to consumers. The company has two reportable segments: Progressive Leasing, an in-store, app-based, and e-commerce point-of-sale lease-to-own solutions provider; and Vive Financial (Vive), an omnichannel provider of second-look revolving credit products. The majority of the revenue of the company is earned through the Progressive Leasing segment.